Is Aspen Pharmacare (APNHY) Outperforming Other Medical Stocks This Year?

Zacks
Abrir en Zacks
Is Aspen Pharmacare (APNHY) Outperforming Other Medical Stocks This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Aspen Pharmacare (APNHY) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.

Aspen Pharmacare is one of 916 companies in the Medical group. The Medical group currently sits at #7 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Aspen Pharmacare is currently sporting a Zacks Rank of #2 (Buy).

The Zacks Consensus Estimate for APNHY's full-year earnings has moved 7.6% higher within the past quarter. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

Based on the latest available data, APNHY has gained about 46.3% so far this year. Meanwhile, the Medical sector has returned an average of 8.6% on a year-to-date basis. This means that Aspen Pharmacare is outperforming the sector as a whole this year.

Another Medical stock, which has outperformed the sector so far this year, is Aveanna Healthcare (AVAH). The stock has returned 61.1% year-to-date.

For Aveanna Healthcare, the consensus EPS estimate for the current year has increased 14.1% over the past three months. The stock currently has a Zacks Rank #2 (Buy).

To break things down more, Aspen Pharmacare belongs to the Medical - Generic Drugs industry, a group that includes 12 individual companies and currently sits at #88 in the Zacks Industry Rank. On average, stocks in this group have gained 15.9% this year, meaning that APNHY is performing better in terms of year-to-date returns.

On the other hand, Aveanna Healthcare belongs to the Medical - Outpatient and Home Healthcare industry. This 14-stock industry is currently ranked #103. The industry has moved +29.1% year to date.

Investors with an interest in Medical stocks should continue to track Aspen Pharmacare and Aveanna Healthcare. These stocks will be looking to continue their solid performance.

Radical New Technology Could Hand Investors Huge Gains

Quantum Computing is the next technological revolution, and it could be even more advanced than AI.

While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.

Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power .

Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.

See Top Quantum Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Aspen Pharmacare (APNHY): Free Stock Analysis Report
 
Aveanna Healthcare Holdings Inc. (AVAH): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research